MELAR ACQUISITION CORP. I C/WTS EXP 01/06/2031 (TO PUR COM)

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

MACIW

Earnings Watch

MELAR ACQUISITION CORP. I C/WTS EXP 01/06/2031 (TO PUR COM) | 10-Q: FY2026 Q1 Revenue: USD 0

MACI

<p>Melar Acquisition I reported no operating revenues for the year, with a net income of $5.54 million primarily from interest and dividends from its IPO trust account. The company completed its IPO, raising $160 million for a future business combination but has not commenced operations. Activities focused on target evaluation and due diligence for a merger with Everli. No earnings per share were disclosed, and the company incurred general and administrative expenses without generating any revenues.</p>

TradingView

Melar Acquisition Corp I

Melar Acquisition I 10-K: $0 Revenue, $5.54M Net Income from Trust Interest

MELAR ACQUISITION CORP. I C/WTS EXP 01/06/2031 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 0

MELAR ACQUISITION CORP. I C/WTS EXP 01/06/2031 (TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD 0.07

MELAR ACQUISITION CORP. I C/WTS EXP 01/06/2031 (TO PUR COM)(MACIW.US)

MELAR ACQUISITION CORP. I C/WTS EXP 01/06/2031 (TO PUR COM) | 10-Q: FY2026 Q1 Revenue: USD 0

Melar Acquisition I 10-K: $0 Revenue, $5.54M Net Income from Trust Interest

MELAR ACQUISITION CORP. I C/WTS EXP 01/06/2031 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 0

MELAR ACQUISITION CORP. I C/WTS EXP 01/06/2031 (TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD 0.07